Cell-Penetrating TLR Inhibitor Peptide Ameliorates Experimental Autoimmune Encephalomyelitis and Promotes Efferocytosis in Microglia and Macrophages

Toll-like receptor (TLR) signaling contributes to inflammatory activation during autoimmune neuroinflammation. We previously demonstrated that a cell-penetrating TLR inhibitory peptide (cpTLR-i), designed to interfere with TLR adaptor recruitment, alleviated experimental colitis through functional modulation of macrophages. Here, we investigated the therapeutic and immunomodulatory effects of cpTLR-i in experimental autoimmune encephalomyelitis (EAE). cpTLR-i suppressed inflammatory mediator production in activated BV2 microglia while preserving MHC class II expression. Systemic cpTLR-i treatment delayed EAE onset, reduced disease severity, and attenuated CNS inflammation and demyelination. Immune profiling revealed reduced granulocyte accumulation and type 1 CD4+ T cells, increased FoxP3+ regulatory T cells, and functional reprogramming of microglia and infiltrating macrophages. Notably, cpTLR-i enhanced apoptotic-cell uptake by microglia and macrophages in vitro and induced an efferocytosis-associated program characterized by increased LXRα and CD36 expression even in the absence of exogenous TLR ligands. Pharmacological inhibition further implicated LXR signaling in this response, while cpTLR-i altered SOCS/STAT3 signaling, revealing an unexpected association between modulation of TLR signaling and signaling networks involved in the regulation of efferocytosis. These findings demonstrate that cpTLR-i not only suppresses inflammatory responses but also promotes pro-resolving functions of microglia and macrophages, suggesting that selective modulation of TLR signaling represents a potential therapeutic strategy for neuroinflammatory diseases.

Authors

Institutions

Publication Details

Journal
International Journal of Molecular Sciences
Published
2026-11-12
DOI
https://doi.org/10.3390/ijms272210132
Primary Topic
Neuroinflammation and Neurodegeneration Mechanisms
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Cell-Penetrating TLR Inhibitor Peptide Ameliorates Experimental Autoimmune Encephalomyelitis and Promotes Efferocytosis in Microglia and Macrophages

Seongwon Pak, Yejin Lee, Keunwook Lee, Hangyeol Park et al.
International Journal of Molecular Sciences
Neuroinflammation and Neurodegeneration Mechanisms
article

Cell-Penetrating TLR Inhibitor Peptide Ameliorates Experimental Autoimmune Encephalomyelitis and Promotes Efferocytosis in Microglia and Macrophages

Seongwon Pak, Yejin Lee, Keunwook Lee, Hangyeol Park, Misu Kim
article en

Abstract

Toll-like receptor (TLR) signaling contributes to inflammatory activation during autoimmune neuroinflammation. We previously demonstrated that a cell-penetrating TLR inhibitory peptide (cpTLR-i), designed to interfere with TLR adaptor recruitment, alleviated experimental colitis through functional modulation of macrophages. Here, we investigated the therapeutic and immunomodulatory effects of cpTLR-i in experimental autoimmune encephalomyelitis (EAE). cpTLR-i suppressed inflammatory mediator production in activated BV2 microglia while preserving MHC class II expression. Systemic cpTLR-i treatment delayed EAE onset, reduced disease severity, and attenuated CNS inflammation and demyelination. Immune profiling revealed reduced granulocyte accumulation and type 1 CD4+ T cells, increased FoxP3+ regulatory T cells, and functional reprogramming of microglia and infiltrating macrophages. Notably, cpTLR-i enhanced apoptotic-cell uptake by microglia and macrophages in vitro and induced an efferocytosis-associated program characterized by increased LXRα and CD36 expression even in the absence of exogenous TLR ligands. Pharmacological inhibition further implicated LXR signaling in this response, while cpTLR-i altered SOCS/STAT3 signaling, revealing an unexpected association between modulation of TLR signaling and signaling networks involved in the regulation of efferocytosis. These findings demonstrate that cpTLR-i not only suppresses inflammatory responses but also promotes pro-resolving functions of microglia and macrophages, suggesting that selective modulation of TLR signaling represents a potential therapeutic strategy for neuroinflammatory diseases.

International Journal of Molecular SciencesVol. 27(22)
Hallym University (KR)
Ministry of Science and ICT, South Korea
Good health and well-being
Neuroinflammation and Neurodegeneration Mechanisms
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon